Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif

Background<p>Muscle wasting and sarcopenia in advanced breast cancer correlates with poor outcomes. The serum creatinine-to-cystatin C ratio (CCR) is a potential muscle mass biomarker, but its prognostic value in advanced breast cancer is unclear.</p>Methods<p>This multicenter retr...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Huijie Deng (5664421) (author)
Diğer Yazarlar:	Jiacheng Yang (4867897) (author), Guanyu Zheng (602277) (author), Biyao Zhang (3160059) (author), Yuzhou Wang (600730) (author), Yuye Wu (22381971) (author), Shufen Mo (21743543) (author), Shengchao Huang (22686392) (author), Yuanqi Zhang (18483375) (author), Lixia Li (407712) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Clinical and Sports Nutrition breast cancer creatinine cystatin C creatinine–cystatin C muscle mass sarcopenia mortality
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

İlk yorumlayan siz olun!

Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif

Benzer Materyaller